SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-017332
Filing Date
2017-08-11
Accepted
2017-08-11 09:10:09
Documents
61
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q 2Q 2017 clsd-10q_20170630.htm 10-Q 1236253
2 EX-31.1 clsd-ex311_6.htm EX-31.1 15281
3 EX-31.2 clsd-ex312_8.htm EX-31.2 15276
4 EX-32.1 clsd-ex321_7.htm EX-32.1 9010
  Complete submission text file 0001564590-17-017332.txt   4928681

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT clsd-20170630.xml EX-101.INS 1109328
6 XBRL TAXONOMY EXTENSION SCHEMA clsd-20170630.xsd EX-101.SCH 42236
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE clsd-20170630_cal.xml EX-101.CAL 47929
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE clsd-20170630_def.xml EX-101.DEF 99424
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE clsd-20170630_lab.xml EX-101.LAB 302152
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE clsd-20170630_pre.xml EX-101.PRE 217248
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA 2Q 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

IRS No.: 452437375 | State of Incorp.: GA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 171023172
SIC: 2834 Pharmaceutical Preparations